1. Introduction
===============

A variety of nucleic acid amplification techniques were developed in the mid to late 1980\'s. These include the polymerase chain reaction (PCR) ([@bib69]), ligation-mediated amplification ([@bib107]) and transcription-based amplification ([@bib52]). Since then, these techniques have been refined and alternative approaches have been developed for amplification (e.g. transcription-mediated amplification (TMA), nucleic acid sequence-based amplification (NASBA), ligase chain reaction (LCR), strand displacement amplification (SDA), linear linked amplification, see [@bib66] for an overview). None of these techniques have achieved the same widespread research application as PCR, most likely due to the simplicity and cost-effectiveness of PCR. However, some of these techniques have been incorporated into clinical diagnostic assays (e.g. SDA is a platform technology used by Becton Dickinson for *Mycobacteria* and *Chlamydia* detection, NASBA is used by Biomérieux for HIV-1, CMV and Enteroviruses, TMA is used by Gen-Probe for the detection of *Mycobacteria*, *Neisseria* and *Chlamydia*). As an adjunct to the emerging amplification technologies that are rapidly being developed, conventional amplification techniques continue to play an integral role in characterising and genotyping parasites for medical, environmental and epidemiological investigations. Techniques such as amplified restriction fragment length polymorphism (AFLP), PCR-restriction fragment length polymorphism (PCR-RFLP) and random amplified polymorphic DNA (RAPD) are currently employed to answer specific biological and evolutionary questions and these techniques have been the subject of numerous reviews (e.g. [@bib62], [@bib66], [@bib89]). The greatest recent advancement in amplification technology has been the development of systems that allow monitoring of amplification in real-time. This paper will provide an overview of recent developments in amplification and detection technologies, with a focus on real-time detection chemistries.

1.1. Real-time amplification
----------------------------

The first real-time amplification system used ethidium bromide and a mounted CCD camera to monitor PCR amplification in a closed reaction tube ([@bib38]). Since then, significant advancements have been made in technology and software exploiting Higuchi\'s initial principle of monitoring changes in amplification signal with time. As a result, real-time PCR now provides researchers and diagnostic laboratories with additional tools for disease diagnosis, identification of species, quantifying gene expression, single nucleotide polymorphism (SNP) detection and monitoring infection loads during therapy. There are many fluorescent detection chemistries currently employed in real-time PCR assays and while there may be superficial similarities between some chemistries, specific assay design criteria need to be adhered to for each chemistry application. (Readers are directed to a recently published text book for design criteria ([@bib23]).)

The advent of real-time PCR has overcome a number of short-comings of conventional PCR. Real-time PCR readily allows quantitation of DNA over a broad dynamic range and it is a closed-tube format that requires no post PCR handling for identification of amplicons, reducing the potential for sample contamination and making the entire process more amenable to high throughput analysis. For quantitation, real-time PCR exploits the proportional relationship between the cycle where exponential amplification is detected (the threshold cycle or *C* ~t~) and the starting number of copies of the target nucleic acid fragment. In order to do this, standards with defined numbers of copies of the target fragment are used to generate a standard curve (based on *C* ~t~ value versus copy number) and the gene copy number in an unknown sample is estimated by comparison to this standard curve ([@bib82]). Closed tube verification of the amplification of the correct fragment can be achieved by DNA melting curve analysis, which is analogous to the detection of a band by conventional gel electrophoresis. In the case where intercalating dyes are used, the dissociation kinetics of the entire amplified fragment is measured, and plotting the first derivative of the melting curve versus temperature allows determination of the melting temperature of the product. Probe:amplicon hybrids can be analysed in a similar fashion, except the melting temperature is determined by measuring the dissociation of the probe from target DNA, rather than measuring the melting temperature of the whole of the amplified fragment. In both cases, the melting temperature is affected by the GC content of the DNA duplex (the higher the GC, the higher the melting temperature), the absolute order of the bases in the sequence and the size of the amplicon or probe:target hybrid.

1.2. Real-time detection chemistries
------------------------------------

The initial development of real-time PCR made use of the double-stranded DNA (dsDNA)-specific intercalating dye ethidium bromide ([@bib38]). dsDNA-specific intercalating dyes exhibit little or no fluorescence when free in solution ([Fig. 1](#fig1){ref-type="fig"} a) but produce a large quantum yield increase in fluorescence when bound to dsDNA and exposed to the appropriate wavelength of light ([Fig. 1](#fig1){ref-type="fig"}b). SYBR Green I ([@bib6]) is currently the industry standard, although the use of other dyes has been described (e.g. BEBO ([@bib9]), LC Green ([@bib106]), SYTO9 ([@bib67])). Intercalating dyes are the most cost effective chemistry and are possibly now the most widely used detection chemistry, particularly for gene expression studies. Caution must be taken when using SYBR Green I, however, as there are disadvantages that limit its ease of use. In general, reaction conditions require further optimisation by including additional reagents to improve reaction efficiency, such as DMSO ([@bib45]), BSA and Triton X-100 ([@bib47]). Depending on the reaction conditions, SYBR Green I also appears to be inhibitory to PCR in a concentration dependent manner ([@bib67], [@bib70], [@bib106]) and the degradation products of the dye have also been reported to be inhibitory to PCR ([@bib47]). In addition, the preferential binding of SYBR Green to specific amplicons during multiplex PCR limits its use for this application ([@bib30]). Recent work describing the evaluation of SYTO9 for real-time PCR has found that this new dye is much less inhibitory to PCR compared with SYBR Green I and that it does not appear to exhibit preferential binding to specific amplicons, allowing it to be used to analyse multiplex PCRs by DNA melting curve analysis ([@bib67]). In addition, SYTO9 appears to be much more robust and reliable for DNA melting curve analysis compared to SYBR Green I, making melting curve analysis a more reliable tool for genetic discrimination/identification ([@bib67]). Intercalating dyes are cost efficient when compared to probe based detection systems and so are the first choice for many applications in research and diagnostics. One of the main advantages of this chemistry is the confirmation of amplicons by melt curve analysis, with each amplicon having a specific melting temperature value. A disadvantage of using these dyes is that any double stranded DNA will be detected, e.g. non-specific amplicons and primer--dimers, which may cause problems with the accuracy of quantitative PCR if they are not resolved by either re-designing primers or acquiring data above the temperature where non-specific products are observed. The use of SYBR Green I for real-time PCR of parasites (excluding bacteria and viruses) has largely been limited to protozoans, including high through-put antimalarial drug screening ([@bib90]), genotyping of *Cryptosporidium parvum* ([@bib103]), and quantitative detection of *Leishmania* ([@bib72]), *Neospora* ([@bib18]), *Toxoplasma* ([@bib19]) and *Trypanosoma brucei* ([@bib7]). There have been limited reports on the use of SYBR Green I for the detection of nematodes ([@bib61]) and study of nematode gene regulation ([@bib57]). There has been a single report of the application of SYTO9 for the identification of *Giardia*, where amplification and melting curve analysis of a fragment of the *gdh* locus allowed discrimination of *Giardia duodenalis* Assemblages A, B and F and *Giardia ardeae* ([@bib67]).Fig. 1Schematic of commonly used real-time PCR chemistries. Unbound intercalating dye is not fluorescent (a) but will produce a quantum yield increase in fluorescence upon binding to double-stranded DNA (b). Taqman probes cannot fluoresce when intact due to the proximity of the reporter and quencher molecule (c), but will produce fluorescent signal following hydrolysis by *Taq* polymerase and release of the reporter molecule (d). The secondary structure of MGB Eclipse probes causes the quencher and reporter molecules to be in close proximity so that the reporter will not fluoresce (e), but once bound to target DNA the probe is stabilised by the minor groove binder and separates the quencher and reporter sufficiently to allow fluorescence (f). Molecular beacons hold the quencher and reporter in close proximity via a stem loop structure, preventing fluorescence when not bound (g) but allowing fluorescence once bound to the target DNA (h). FRET probes anneal to target sequences and energy transfer from the donor to reporter molecule (i) results in increased fluorescence of the reporter molecule (j). Intercalating dyes will not fluoresce unless bound to double-stranded DNA and so cannot act as energy donors when in the unbound state for iFRET reactions (k). Upon binding of the intercalator and iFRET probe, energy transfer can occur, resulting in production of fluorescence (l). Scorpion probes are held in a stem-loop structure that prevents probe fluorescence (m), but once incorporated into an amplicon the structure is opened by binding of the loop to complementary sequence within the amplicon (n). Figure adapted from [@bib67].

Taqman (hydrolysis probes, 5′ nuclease assay) ([@bib36]) and 3′ MGB probe technologies both work by a similar principle. Both systems have a 5′ fluorescent reporter molecule (e.g. carboxyfluorescein (FAM)), and a 3′ quencher molecule (e.g. BHQ1 or TAMRA). Taqman probes are typically 20--30 nucleotides in length and the fluorescence of the reporter molecule is quenched at this proximity between reporter and quencher molecule ([Fig. 1](#fig1){ref-type="fig"}c). Hydrolysis of the Taqman probe by the 5′ exonuclease activity of *Taq* DNA polymerase at 60 °C separates the reporter and quencher molecule and a signal is emitted by the reporter molecule that is detected by the real-time PCR instrument ([Fig. 1](#fig1){ref-type="fig"}d). The incubation temperature of DNA synthesis step is critical because at higher temperatures (e.g. 72 °C), which are normally used for DNA synthesis in conventional PCR, the *Taq* DNA polymerase will displace the probe rather than degrade it. As a result of probe degradation, fluorescent signal increases as a function of the number of amplification cycles and allows specific detection and quantitation of the target DNA. In contrast, 3′ MGB probes have a 3′ minor groove-binding moiety in addition to a reporter and quencher molecule, resulting in improved primer binding (by increasing the effective primer melting temperature) and allowing the use of shorter probes, resulting in better efficiency ([@bib51]). Taqman probes are one of the most widely used chemistries because assay design is relatively simple and assays are generally robust. Taqman probes do not allow confirmation that the correct fragment has been amplified (other than by running a gel), and as a result it is particularly important to validate the specificity of primer/probe combinations. Multiplexing Taqman assays is achieved using probes labelled with different reporter molecules that have distinct fluorescence properties (namely excitation/emission maxima). The combinations of fluorophores that can be used is dependant on the technical specifications of the real-time PCR instrument used (an upper limit of six fluorophores can be detected on some instruments). Taqman probes allow presence/absence detection of a particular target sequence but do not allow genetic discrimination unless used in a multiplex format. Taqman assays have been used for the detection of numerous parasites including *Cryptosporidium* ([@bib27], [@bib37], [@bib48]), *Giardia* ([@bib10]), *Leishmania* ([@bib31], [@bib78]), *Myxobolus cerebralis* ([@bib16], [@bib49]), *Plasmodium* ([@bib11], [@bib104]), *Theileria* ([@bib43]) and *Toxoplasma gondii* ([@bib42]). In these cases the Taqman assays were used for detection but not differentiation of parasites. The only reported use of Taqman probes for parasite differentiation has been for trichostrongyle nematodes, where multiplex assays were developed for the pair-wise differentiation of *Haemonchus contortus*, *Ostertagia leptospicularis*, *Tricginstohgylus colubriformis* and *Cooperia curticei* ([@bib100]). Molecular beacons ([@bib74]) and MGB Eclipse probes ([@bib1]) both use secondary structure (a stem-loop in the case of molecular beacons) to hold a reporter molecule and quencher in close proximity when the probe is in solution ([Fig. 1](#fig1){ref-type="fig"}e for MGB Eclipse probes, [Fig. 1](#fig1){ref-type="fig"}g for molecular beacons), preventing the production of any fluorescent signal. When either type of probe anneals to target DNA, they unfold and there is sufficient distance between the reporter and quencher molecules to allow fluorescence ([Fig. 1](#fig1){ref-type="fig"}f and h). Unlike Taqman probes, MGB Eclipse probes and molecular beacons are not hydrolysed because the extension temperatures are 72 °C or higher. However, MGB Eclipse probes are claimed to be more stable than molecular beacons (presumably because of the presence of the 5′ MGB moiety) and appear to produce better signal to noise ratio than molecular beacons (<http://www.epochbio.com/products/mgbe_how_it_works.htm>). Both MGB Eclipse probes and molecular beacons can be used for DNA melting curve analysis (measuring the dissociation kinetics of the release of the bound probe to target DNA), allowing further genetic characterisation of the amplified DNA. The use of MGB Eclipse probes appears to be limited in the literature, although they have been demonstrated to be useful for SNP typing ([@bib8]). Molecular beacons have been widely used for a variety of pathogens (e.g. *Bordetella* ([@bib75]) and Hepatitis C ([@bib111])), particularly in combination with NASBA (e.g. [@bib32]), but have only been applied to *Plasmodium* ([@bib13], [@bib84]) and *Entamoeba histolytica* ([@bib79]) in terms of parasites.

Fluorescence (or forster) resonance energy transfer (FRET)-based assays rely on energy transfer between a 3′ donor fluorophore and 5′ reporter fluorophore on separate probes ([Fig. 1](#fig1){ref-type="fig"}i and j), rather than the quenching of a fluorophore as seen with MGB Eclipse, molecular beacon and Taqman probes. Melt curve analysis in FRET assays measure the temperature at which the bound probes are dissociated from the target amplicon and not the melting temperature of the entire amplicon as is the case when using intercalating dyes. Thus a single primer set may be used to amplify a region of interest, with species/strain discrimination possible by designing the FRET probes to bind to variable regions within the region bound by the primer set used for amplification. This technology lends itself to SNP detection, as a single mismatch between the probe and target sequences will yield a sufficiently different melting temperature to allow detection. iFRET ([@bib39]) is a variation of FRET and uses an intercalating dye (SYBR Green I) as the donor fluorophore and only a single probe with a reporter molecule ([Fig. 1](#fig1){ref-type="fig"}k and l). iFRET appears to have advantages over FRET in terms of cost and signal strength ([@bib39]) but does not appear to have been widely used. FRET assays have been used for the clinical diagnosis of *Toxoplasmagondii* infections ([@bib76], [@bib87]) and to study the transmission of *T. gondii* between mother and foetus in an animal model ([@bib26]). In addition, FRET assays have been used to detect and discriminate species/genotypes of *Cryptosporidium* ([@bib58]), and to detect, quantitate and differentiate the three clinically relevant groups of *Leishmania* ([@bib86]). Although a powerful tool, FRET assays are more cumbersome to optimise than Taqman assays and require more care when used in quantitation because excessive levels of target DNA can adversely affect the amplification signal (known as a "hook" effect, which is caused by excess amplicon interfering with probe binding) and melting curve analysis.

Scorpion primers ([@bib92]) perform the dual function of probe and primer. In structure Scorpion primers are essentially a molecular beacon with a primer linked to the 3′ end of the stem of the beacon ([Fig. 1](#fig1){ref-type="fig"}m). The link between the beacon section and the primer has a PCR blocker to prevent replication of the beacon sequence. The loop of the beacon is complimentary to the sequence synthesised immediately 3′ from the primer. Following primer extension, denaturation and annealing, the loop sequence hybridises to the newly synthesised complementary sequence adjacent to the primer, resulting in a separation between the quencher and fluorophore and production of a fluorescent signal ([Fig. 1](#fig1){ref-type="fig"}n). Unlike molecular beacons, Scorpion probes cannot be used for DNA melting curve analysis. The proximity of the probe to the target region means that the interaction is more efficient than other probe formats, allowing good sensitivity. Despite this advantage, the application of Scorpion probes has been relatively limited in terms of pathogen diagnosis, with reports on the use of Scorpions for quantitation of HIV-1 ([@bib80]) and differentiation of *Giardia* assemblages A and B directly from faecal samples using a multiplex assay ([@bib71]).

1.3. Nucleic acid sequence-based amplification
----------------------------------------------

NASBA is an isothermal amplification technique making use of a dual function reverse transcriptase/DNA polymerase, RNA polymerase, RNaseH and a T7 promoter-labelled target-specific primer ([@bib33]). TMA works by a similar principle to NASBA, except that the assay relies on the RNaseH activity of the reverse transcriptase, rather than using a separate enzyme with RNaseH activity. This combination of enzymes and primers targets a specific RNA transcript and initially produces an RNA:DNA hybrid fragment with a T7 promoter ([Fig. 2](#fig2){ref-type="fig"} ). The RNA in this hybrid is degraded by the RNaseH and the DNA is extended to form a dsDNA fragment with a T7 promoter, forming a template for the production of more RNA transcripts by T7 RNA polymerase. These transcripts can then be used for the production of additional DNA fragments with T7 promoters. The reaction is self-sustaining, giving rise to an alternative name for this process, self-sustained sequence replication or 3SR. DNA contamination of samples does not affect this process, which means that RNA quantitation can be conducted from crude cell extracts. NASBA is not widely used as the cost of commercial kits is prohibitive and there are difficulties in reliably preparing an in-house NASBA mastermix. To date, NASBA has been most widely used for virus detection, most typically using commercial NASBA kits and probe-based chemiluminescent detection of the amplified RNA ([@bib53], [@bib97], [@bib105], [@bib108]). The application of NASBA to detect bacterial pathogens ([@bib20]) and *Cryptosporidium* ([@bib4]) has been more limited. More recently, NASBA technology has been coupled with molecular beacons for monitoring product generation in real-time ([@bib56]) and has been used to quantify *Plasmodium* ([@bib83], [@bib84]) and viruses ([@bib3], [@bib15], [@bib34], [@bib68]). The sensitivity of NASBA is often greater than conventional reverse transcription PCR ([@bib59], [@bib101]), and NASBA has been reported to be superior for the unambiguous detection of mRNA in the presence of DNA ([@bib88]). In addition to real-time detection, NASBA has also been combined with liposome signal amplification technology (<http://www.ibi.cc/advantages_of_liposomes.htm>) to develop biosensors for *Escherichia coli* ([@bib5]), *Bacillus anthracis* ([@bib5]), *Cryptosporidium* ([@bib5], [@bib24], [@bib25]) and Dengue virus ([@bib112]).Fig. 2Schematic representation of NASBA. RNA (red wavy line) is converted to double-stranded DNA with a T7 promoter using reverse transcriptase, RNaseH and a primer with a T7 promoter. The DNA is used as a template by T7 RNA polymerase for the production of multiple copies of antisense RNA (black wavy lines). Each transcript can act as a template for the production of additional double-stranded DNA templates.

1.4. Ligase chain reaction
--------------------------

The ligase chain (or detection) reaction (LCR) is another amplification technique developed shortly after PCR ([@bib107]). This technique uses a thermostable DNA ligase and four primers, two adjacent forward primers and their complements. There is typically a gap of 1--3 bases between the adjacent primers, which act as templates for ligation by DNA ligase. DNA ligase is highly specific and intolerant to base mismatches, a property exploited for use in real-time detection of SNPs ([@bib17]) and the detection of intra-individual differentiation of species-specific parasitemia for *Plasmodium* sp. ([@bib65]). Uptake of this technology to the routine environment has been slow, possibly due to the market dominance of PCR. Commercial LCR kits (LCx, Abbott laboratories) for *Mycobacterium tuberculosis* seem to perform adequately ([@bib55], [@bib77]), but the *Chlamydia trachomatis* LCx kit had problems with reproducibility and had to be withdrawn from the market due to "high negative control rates resulting in invalid runs and non-repeating positives" (FDA product recall Z-0859-1/Z-0860-1, <http://www.fda.gov/bbs/topics/ENFORCE/2001/ENF00709.html>). This technology holds great promise, particularly for SNP detection and use in microchips ([@bib60]) or with universal microarrays ([@bib14]).

1.5. Strand displacement amplification
--------------------------------------

SDA is another isothermal reaction that was developed at around the same time as NASBA ([@bib102]). This amplification technique makes use of a combination of exonuclease deficient DNA polymerase (Klenow fragment), a restriction endonuclease with a hemiphosphorothioate recognition site, a modified deoxynucleotide to allow the synthesis of hemiphosphorothioated DNA, and two sets of primers ([@bib102]). The first set of primers act in the same way as forward and reverse primers used in PCR, but they have a restriction enzyme recognition site inserted at their 5′-ends. The second set of primers is known as "bumper" primers and these are designed to bind immediately 5′ of the forward and reverse primers. After denaturation of the target DNA, the forward and reverse primers promote the synthesis of hemiphosphorothioated DNA, creating a DNA: hemiphosphorothioated DNA hybrid. These strands are separated by extension of the bumper primers, which displace the newly synthesised hemiphosphorothioated DNA strand. The resulting ssDNA is converted to dsDNA by primer extension using the respective forward or reverse primer. The resulting hemiphosphorothioated dsDNA contains a restriction site and forms the template for SDA. This template is cut by a restriction enzyme to introduce a single stranded nick at the restriction site, which promotes the synthesis of a new strand of DNA by the DNA polymerase as it repairs, the nick in the DNA. The synthesis of the strand of DNA results in the displacement of the old one. Once the hemiphosphorothioated template has been produced, the process is self sustaining.

The original SDA process was not very efficient and it has been improved by incorporating a thermostable polymerase and a different exonuclease to greatly improve the yield and rate of amplification. These new conditions allow a 10^10^-fold amplification of target after 15 min at 60 °C ([@bib93]). SDA can also be used to detect RNA by incorporating a reverse transcription step ([@bib73]). The largest application of SDA has been for clinical diagnosis of pathogenic organisms (HIV-1 ([@bib73]), *M. tuberculosis*, ([@bib64], [@bib93], [@bib99]), *Chlamydia* and *Neisseria* ([@bib21], [@bib96]), pathogenic *E. coli* ([@bib29])).

1.6. 2005 and beyond
--------------------

Research continues into the development of new amplification technologies, with several being described in recent years. One of the most recently described amplification techniques makes use of a DNA helicase to allow isothermal DNA amplification ([@bib98]). A combination of DNA helicase, single-stranded DNA-binding proteins and accessory proteins are used to unwind double-stranded DNA, which can then act as a template for DNA synthesis using primers and a DNA polymerase. This process is the first true isothermal process to be described because there are no other temperature steps required (unlike other isothermal techniques that require an initial denaturation step to initiate the process). Helicase-mediated amplification has been measured in real-time and has been used to detect *Treponema denticola* and *Brugia malayi* ([@bib98]), although further refinements are being made to the assay to improve efficiency and to simplify the reaction by identifying alternative helicases that display activity in the absence of accessory proteins ([@bib2]).

Another technique, rolling circle amplification, has been used recently for in situ genotyping of individual DNA molecules ([@bib54]). This process uses restriction digestion and exonuclease digestion to produce single stranded DNA targets, which can then hybridise specific oligonucleotides (padlock probes). The padlock probes circularise following hybridisation and are then ligated to provide a template for rolling circle amplification, resulting in the incorporation of many copies of the padlock probe into the target strand of DNA. The padlock probe has a specific target sequence, which is then detected using a fluorescent complementary probe, allowing the detection of a single gene within a cell. Rolling circle amplification has also been used to detect minicircle DNA by promoting replication branching and restriction enzyme digestion to produce dsDNA fragments that can be detected using a peptide nucleic acid molecular beacon ([@bib91]). The current technique is rapid but relatively insensitive, although the authors claim that optimisation of the assay volume and detection format should allow detection of 100 copies of target within 50 min. Padlock probes have been used to detect plant pathogens ([@bib94]).

A more established recently developed technique is multiplex ligation-dependent probe amplification (MLPA), which makes use of both ligation and PCR ([@bib85]). This process has multiple components and steps ([Fig. 3](#fig3){ref-type="fig"} ). Essentially it uses two DNA fragments, the first with a 5′ fluorescent label, a universal forward primer and a target-specific recognition sequence at the 3′ end, the second with a target-specific recognition sequence at the 5′ end (designed to hybridise next to the specific sequence on the 3′ end of the other fragment), a non-specific stretch of DNA of a defined length termed a "stuffer" sequence and a universal reverse primer at the 3′ end. MLPA has two steps, the first is ligation of the two fragments on binding to the target DNA, and the second is PCR amplification of the ligated probe. Multiplexing is achieved by varying the length of the stuffer sequence for each set of probes used in the assay. Amplification is detected by sequence-grade electrophoresis such as capillary electrophoresis and it is claimed that this approach allows relative quantitation ([@bib85]). Since the target sequence for this assay is short it is ideal for the detection of fragmented DNA, such as that recovered from formalin preserved material. Although used widely for the detection of human genetic disorders and cancers, MLPA has not been applied in a clinical microbiology context.Fig. 3Schematic representation of MLPA. A specific two component probe is used for the detection of each sequence type of interest. Each probe element has a region complementary to the sequence of interest. On binding to the sequence of interest the probe elements are ligated and the intact probe is amplified using universal primers. Probes are differentiated on the basis of size, which is accomplished by varying the length of a "stuffer" sequence that has no similarity to the sequence of interest. Typically the probe is fluorescently labelled to enable detection and quantitation of band intensity by capillary electrophoresis.

In addition to new amplification systems, advances are also being made into new techniques for detecting amplification. Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry has been used to directly detect amplification products from PCR ([@bib40]) and LCR ([@bib46]), and to analyse restriction digests ([@bib95]). Instead of detecting the amplified DNA, an alternative approach has been developed using photo-cleavable linkers (as seen with the Masscode or Masstag systems), providing an interesting alternative to the use of fluorophores for PCR detection. These systems involve linking a small molecular weight molecule to the 5′ end of a nucleotide, which is used as a primer in an allele specific SNP assay, or as a probe for pathogen detection. Detection of these linkers (also called "tags" or "codes") is achieved by MALDI-TOF mass spectrometry (see <http://www1.qiagen.com/literature/qiagennews/0201/1016749_QNews22001p11-12.pdf> or <http://www.bioserve.com/departments/snp_masscode.cfm> for further information). Up to 30 linkers can be used, enabling high throughput screening of SNPs ([@bib35], [@bib50], [@bib81], [@bib109]). Masscode technology has been applied to the detection of a variety of respiratory pathogens, including *Legionella*, Influenza and *Adenovirus*, and levels of detection ranged from 100 to 5000 DNA/RNA copies depending on the pathogen ([@bib12]). The use of MALDI-TOF-based technologies, however, is prohibitive to most laboratories due to the expense associated with purchasing a mass spectrometer, and this is reflected in the relatively limited application of the technology. Considering that there are many more cost effective technologies for high-throughput screening it is debateable whether this technology will become widely adopted, and at the moment the use of such technology is akin to routinely using electron microscopy to examine faecal smears in a clinical laboratory.

Possibly the most rapidly developing area of emerging technology is nanotechnology, which is driving the development of lab-on-a-chip systems (see [@bib22], [@bib28] for reviews). Many systems are in development that will miniaturise conventional and real-time amplification systems, allowing extremely rapid analysis of sub-microlitre volume samples (e.g. nanolitre Taqman multiplex PCR, ([@bib63])). There are numerous detection systems ranging from gold nanoparticles tagged with short segments of DNA to multicolour optical coding for biological assays that have been achieved by embedding different-sized quantum dots into polymeric microbeads (reviewed by [@bib41]). Co-migration electrophoregrams in combination with restriction enzyme digest have been used on chip devices for discrimination and quantitation of PCR products ([@bib110]), and semi-quantitation of SARS-coronavirus has been described ([@bib44]). Certainly many challenges lie ahead in this area, particularly to obtain a cost effective, workable, user friendly interface and end point result analysis system, but if successful its potential applications in the biological setting are far reaching.

2. Summary
==========

Numerous technologies exist for nucleic acid amplification and detection. The choice of which method to use will be dictated by the nature of the sample and the biological question being addressed, as well as the cost and ease of use of the technique, including assay design and ease of data interpretation. For example, NASB A has many advantages over reverse transcription PCR for the detection of RNA, but these need to be balanced against the relative ease of assay design and cost of reagents. There are numerous real-time PCR instruments on the market, and numerous detection chemistries, each with advantages and disadvantages, and choosing the right system is reliant upon its intended use. Lab-on-a-chip devices have the potential to revolutionise medical management and environmental monitoring but more attention is needed to make these systems workable so that they can be taken out of the lab and put into use in field environments. It is almost certain that additional techniques will be developed in the near future that will be faster, cheaper, and easier to use. However, the tools currently available offer a myriad of options to answer specific biological questions.
